Fig. 2
From: Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model
Representative images of ocular surface staining of BALB/c mice in the RCI001, 1% prednisolone acetate (PDE), and 5% Lifitegrast groups
Fig. 2 | Eye and Vision